相关实验视频
Updated: Jun 8, 2025

07:22
Basophil Activation Test for Allergy Diagnosis
Published on: May 31, 2021
8.1K
生物制剂在食物过敏管理中的使用
1From the Section of Allergy and Immunology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.
Allergy and asthma proceedings
|November 9, 2024
概括
管理食物过敏涉及患者的重大负担. 像OIT和SLIT这样的新疗法提供了潜在的免疫调节,而奥马利祖马布增加了反应值,指导了偏好敏感的护理.
科学领域:
- 免疫学 免疫学 免疫学
- 过敏和免疫学 过敏和免疫学
- 临床医学 临床医学
背景情况:
- 食物过敏严重影响患者和家人,导致社会隔离,焦虑和生活质量下降.
- 过敏学家/免疫学家进行有效的风险沟通至关重要,特别是在致命食物过敏的发病率低的情况下.
- 随着食物过敏治疗的不断发展,需要做出明智的决策.
研究的目的:
- 审查当前和新兴的食物过敏治疗方法.
- 讨论过敏学家/免疫学家在患者教育和风险传播中的作用.
- 突出了共同决策在管理食物过敏的重要性.
主要方法:
- 对当前的食物过敏治疗方法的文献综述,包括口服免疫疗法 (OIT),舌下免疫疗法 (SLIT) 和omalizumab.
- 治疗疗效的分析,潜在的免疫调节作用,以及与年龄相关的考虑.
- 在食品过敏管理的背景下讨论共享决策原则.
主要成果:
- 对于年幼的儿童来说,OIT和SLIT是有前途的,具有潜在的免疫调节作用.
- 奥马利祖马布增加了反应性值,但缺乏免疫调节的证据;在幼儿中使用它可能代表了免疫调节的机会.
- 共享决策对于食品过敏管理中的偏好敏感护理至关重要.
结论:
- 现代的食物过敏治疗方法,包括OIT,SLIT和奥马利祖马布,提供各种管理策略.
- 了解每种治疗的独特机制和益处对于最佳的患者护理至关重要.
- 整合共享决策确保患者的偏好指导食物过敏治疗的选择.
相关概念视频
Inflammatory Bowel Disease IV: Pharmacological Management
114
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
114
Hypersensitivities
522
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
522
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
117
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
117
Allergic Drug Reactions
812
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
812
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
237
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
237
Cross-reactivity
31.0K
Overview
31.0K

